ACN Newswire

Sat Feb 13

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

Written by ACN Newswire

FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, CHINA, Feb 12, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China,...

ACN Newswire

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

How Eurasia's Tianshan mountains set a stage that changed the world

Feeding frenzy: public accuse the media of deliberately fuelling shark fear

Too many Australians miss out on timely dental care – Labor's pledge is just a start

7 Reasons To Travel Around The World While You Can

More green, more ‘zzzzz’? Trees may help us sleep

After last summer's fires, the bell tolls for Australia’s endangered mountain bells

Climate explained: what the world was like the last time carbon dioxide levels were at 400ppm

Four lessons we must take away from the Christchurch terror attack

Who can break up the 'Big 3' monopoly on men's tennis? Here's what the numbers say

Small budgets, big ideas — what a viral adult film awareness campaign tells us about New Zealand advertising

Esports are taking off and the Commonwealth Games needs to catch up